© Copyright 2026 American Medical Association. All rights reserved.
Exome sequencing, as described by CPT® Code 81415, refers to a specialized molecular genetic testing technique that focuses on the exome, which is the portion of the genome that contains the coding sequences of genes. This procedure is particularly valuable in the context of unexplained constitutional or heritable disorders or syndromes, where traditional diagnostic methods may not yield conclusive results. The exome encompasses approximately 180,000 exons, which represent about 1-2% of the entire genome but are responsible for approximately 85% of known heritable disease-causing mutations. By utilizing whole exome sequencing (WES), healthcare providers can identify genetic variants that may be responsible for a patient's condition, especially in cases where multiple anomalies are present and a genetic disorder is suspected. The testing process involves obtaining a blood sample through a separately reportable venipuncture, which is then analyzed using Next Generation Sequencing (NGS) technology. This advanced method allows for the detection of various genomic variants, including single nucleotide variants (SNVs), small insertions or deletions of DNA (indels), copy number variants (CNVs), and other structural variants (SVs). The results of this analysis can provide critical insights into the genetic underpinnings of a patient's condition, guiding further clinical management and potential treatment options.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.